Skip to main content

and
  1. No Access

    Article

    Protective Autophagy Attenuates the Cytotoxicity of MTI-31 in Renal Cancer Cells by Activating the ERK Pathway

    The mammalian target of rapamycin (mTOR) is a key regulatory molecular target to treat cancer, and MTI-31 is a potent mTOR inhibitory agent for the therapeutically target of the renal cell carcinoma (RCC). How...

    Yiwen Zang, Chen Yang, Meng-shi Dai, Wenye Zhang in Applied Biochemistry and Biotechnology (2024)

  2. Article

    Correction to: Combining MTI‑31 with RAD001 inhibits tumor growth and invasion of kidney cancer by activating autophagy

    Wenye Zhang, Chen Yang, Lujia Zou, Yiwen Zang, Jimeng Hu in Journal of Applied Genetics (2024)

  3. No Access

    Article

    Combining MTI-31 with RAD001 inhibits tumor growth and invasion of kidney cancer by activating autophagy

    At most of the times, patients who are diagnosed with kidney cancer should be provided with systemic treatment as drug resistance is a challenging issue in the treatment of this disease. The progression of the...

    Wenye Zhang, Chen Yang, Lujia Zou, Yiwen Zang, Jimeng Hu in Journal of Applied Genetics (2024)

  4. Article

    Open Access

    Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment

    Metabolism vulnerability of cisplatin resistance in BCa cells remains to be discovered, which we applied integrated multi-omics analysis to elucidate the metabolism related regulation mechanism in bladder canc...

    Chen Yang, Yuxi Ou, Quan Zhou, Yingchun Liang, Weijian Li in Cell Death & Disease (2023)

  5. Article

    Open Access

    Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer

    Muscle-invasive bladder cancer (MIBC) is one of the most important type of bladder cancer, with a high morbidity and mortality rate. Studies have found that long non-coding RNA (lncRNA) plays a key role in mai...

    Yingchun Liang, Fangdie Ye, Zhang Cheng, Yuxi Ou, Lujia Zou in Cancer Cell International (2021)

  6. Article

    Open Access

    A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer

    The effective treatment and prognosis prediction of bladder cancer (BLCA) remains a medical problem. Ferroptosis is an iron-dependent form of programmed cell death. Ferroptosis is closely related to tumour occ...

    Yingchun Liang, Fangdie Ye, Chenyang Xu, Lujia Zou, Yun Hu, Jimeng Hu in BMC Cancer (2021)

  7. Article

    Open Access

    Ureteral reconstruction using a tapered non-vascularized bladder graft: an experimental study in a canine animal model

    Reconstruction of ureteral defects and strictures remains problematic for urologists. We aimed to investigate the possibility of a tapered non-vascularized bladder graft as a novel substitute for ureteral reco...

    Lujia Zou, Shanhua Mao, Shenghua Liu, Limin Zhang, Tian Yang, Yun Hu in BMC Urology (2017)

  8. No Access

    Article

    Comparison of post-operative intravesical recurrence and oncological outcomes after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma

    To retrospectively evaluate intravesical recurrence and oncological outcomes after open or laparoscopic radical nephroureterectomy (RNU) for the upper urinary tract urothelial carcinoma (UUT-UC).

    Lujia Zou, Limin Zhang, Hu Zhang, Haowen Jiang, Qiang Ding in World Journal of Urology (2014)